Forest Labs Buys Cerexa For $480M
New York-based Forest Laboratories said Thursday that it has acquired Alameda-based Cerexa, a biopharmaceutical company developing injectable antibiotics. The deal was worth $480M in cash. Cerexa is developing injectable antibiotics which are targeted at Gram- positive bacteria like MRSA (methicillin resistant Staphylococcus auerus). The firm's lead candidate is entering Phase III studies.
posted on Friday, December 15, 2006
Related companies:
Forest City Trading Group, LLC
Related stories:
> Montreux Closes $250M Life Sciences Fund
> IBM Buys Unica
> Unchained Labs Gets $13M, Buys Trinean
> Jive Buys Proximal Labs
> Unchained Labs Raises $17M, Buys rap.ID
silicontap.com Home